Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis
- DOI
- 10.1002/pcn5.70332
- Published
- 2026-04-12
- Container
- Psychiatry and Clinical Neurosciences Reports
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/pcn5.70332,
title = {Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis},
author = {Sher Bano and Aashan Ahmad and Abdul Haseeb Mohammed and Ismailova Rushana Nurbekovna and Saja Saad and Noor Fatima and Muhammad Bilal Akbar and Zainab Salahuddin and Sadikun Nabi and Mohammad Mustafa Ababneh and Laiba Ajmal and Sidra Hariss and Hiba Manaf and Farah Saleh and Raouf Khan},
year = {2026},
journal = {Psychiatry and Clinical Neurosciences Reports},
doi = {10.1002/pcn5.70332},
url = {https://doi.org/10.1002/pcn5.70332}
}RIS
TY - JOUR TI - Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis AU - Sher Bano AU - Aashan Ahmad AU - Abdul Haseeb Mohammed AU - Ismailova Rushana Nurbekovna AU - Saja Saad AU - Noor Fatima AU - Muhammad Bilal Akbar AU - Zainab Salahuddin AU - Sadikun Nabi AU - Mohammad Mustafa Ababneh AU - Laiba Ajmal AU - Sidra Hariss AU - Hiba Manaf AU - Farah Saleh AU - Raouf Khan PY - 2026 JO - Psychiatry and Clinical Neurosciences Reports DO - 10.1002/pcn5.70332 UR - https://doi.org/10.1002/pcn5.70332 ER -
APA
Bano, S., Ahmad, A., Mohammed, A. H., Nurbekovna, I. R., Saad, S., Fatima, N., Akbar, M. B., Salahuddin, Z., Nabi, S., Ababneh, M. M., Ajmal, L., Hariss, S., Manaf, H., Saleh, F., & Khan, R. (2026). Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis. Psychiatry and Clinical Neurosciences Reports. https://doi.org/10.1002/pcn5.70332
Source records
- crossref · retrieved 2026-09-26T08:51:10.635Z